Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Q: What does CUSIP 78667J108 represent in this 13F holders report?

CUSIP 78667J108 is the security identifier for SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") used to aggregate holder disclosures.

Q: How many institutions held SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in Q1 2021?

254 institutional investors reported SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 78667J108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
Shares outstanding: 62,650,155
Total 13F shares: 53,088,674
Share change: -695,855
Total reported value: $3,974,807,423
Put/Call ratio: 220%
Price per share: $74.85
Number of holders: 254
Value change: -$71,753,377
Number of buys: 125
Number of sells: 122

Quarterly Holders Quick Answers

What is CUSIP 78667J108?
CUSIP 78667J108 identifies SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 78667J108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	12%	7,806,699	$675,357,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	7.3%	4,599,115	$397,870,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	6.8%	4,283,629	$370,577,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4.6%	2,910,270	$251,767,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.8%	2,357,342	$203,934,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	3.5%	2,194,887	$189,880,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.2%	1,978,811	$171,190,000	—	31 Dec 2020	13F
Artisan Partners Limited Partnership	13F	Company	2.5%	1,592,933	$137,805,000	—	31 Dec 2020	13F
Bellevue Group AG	13F	Company	2.5%	1,567,504	$135,604,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	2.4%	1,532,879	$132,609,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	2.4%	1,506,075	$130,291,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	2.4%	1,484,593	$128,433,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	1.7%	1,094,000	$94,642,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.7%	1,050,000	$90,836,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.2%	733,897	$63,490,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	1.2%	721,108	$62,383,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	1.1%	716,065	$61,946,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	654,760	$56,643,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	638,087	$55,200,000	—	31 Dec 2020	13F
Palo Alto Investors LP	13F	Company	0.94%	590,200	$51,058,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.9%	563,968	$48,789,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.81%	509,133	$44,045,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.8%	499,444	$43,207,000	—	31 Dec 2020	13F
GREAT POINT PARTNERS LLC	13F	Company	0.73%	454,417	$39,312,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.71%	442,000	$38,237,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.7%	440,000	$38,064,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.67%	421,799	$36,490,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.65%	408,800	$35,365,287	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	0.64%	400,000	$34,604,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.62%	389,634	$33,706,000	—	31 Dec 2020	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.56%	353,603	$30,590,000	—	31 Dec 2020	13F
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.	13F	Company	0.5%	314,883	$27,240,528	—	31 Dec 2020	13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	13F	Company	0.49%	308,000	$26,645,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.47%	291,830	$25,247,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.41%	259,349	$22,437,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.41%	257,804	$22,303,000	—	31 Dec 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.41%	255,800	$22,129,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.4%	251,141	$21,727,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.38%	234,939	$20,325,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.35%	222,300	$19,231,000	—	31 Dec 2020	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0.33%	209,402	$18,116,000	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.33%	208,159	$18,008,000	—	31 Dec 2020	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.33%	207,692	$17,967,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.33%	207,207	$17,925,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.33%	206,243	$17,842,000	—	31 Dec 2020	13F
Integral Health Asset Management, LLC	13F	Company	0.31%	195,000	$16,869,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.31%	193,762	$16,766,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.29%	184,558	$15,966,000	—	31 Dec 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.29%	181,650	$15,715,000	—	31 Dec 2020	13F
DAFNA Capital Management LLC	13F	Company	0.29%	181,306	$15,685,000	—	31 Dec 2020	13F

Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q1 2021

As of 31 Mar 2021, Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by 254 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,088,674 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, D. E. Shaw & Co., Inc., Bellevue Group AG, Artisan Partners Limited Partnership, and Invesco Ltd.. This page lists 255 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

244

Q1 2021 holders

254

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.